AU2003202264A1 - Composition and method for inhibiting hypersensitivity - Google Patents

Composition and method for inhibiting hypersensitivity

Info

Publication number
AU2003202264A1
AU2003202264A1 AU2003202264A AU2003202264A AU2003202264A1 AU 2003202264 A1 AU2003202264 A1 AU 2003202264A1 AU 2003202264 A AU2003202264 A AU 2003202264A AU 2003202264 A AU2003202264 A AU 2003202264A AU 2003202264 A1 AU2003202264 A1 AU 2003202264A1
Authority
AU
Australia
Prior art keywords
composition
hypersensitivity
inhibiting
inhibiting hypersensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003202264A
Inventor
Stephen Francis Badylak
Kenneth Robert Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clarian Health Partners Inc
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of AU2003202264A1 publication Critical patent/AU2003202264A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
AU2003202264A 2002-01-11 2003-01-09 Composition and method for inhibiting hypersensitivity Abandoned AU2003202264A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34753902P 2002-01-11 2002-01-11
US60/347,539 2002-01-11
PCT/US2003/000607 WO2003059221A1 (en) 2002-01-11 2003-01-09 Composition and method for inhibiting hypersensitivity

Publications (1)

Publication Number Publication Date
AU2003202264A1 true AU2003202264A1 (en) 2003-07-30

Family

ID=23364141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202264A Abandoned AU2003202264A1 (en) 2002-01-11 2003-01-09 Composition and method for inhibiting hypersensitivity

Country Status (2)

Country Link
AU (1) AU2003202264A1 (en)
WO (1) WO2003059221A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7171060B2 (en) 2017-05-05 2022-11-15 ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション Ocular application of matrix-bound vesicles (MBV)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1180156B (en) * 1984-01-09 1987-09-23 Crinos Industria Farmaco GLYCOPROTEIN-BASED COSMETIC COMPOSITION FOR SKIN TREATMENT
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
AU742457B2 (en) * 1996-08-23 2002-01-03 Cook Biotech, Incorporated Graft prosthesis, materials and methods

Also Published As

Publication number Publication date
WO2003059221A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
AU2003266058A1 (en) Antimicrobial composition and method for use
AU2003234794A1 (en) Composition and method for temporarily fixing solid
AU2003256805A1 (en) Compounds compositions and methods
AU2003284387A1 (en) Delivery composition and method
AU2003287265A1 (en) Cyclooxygenase-2 inhibitory withanolide compositions and method
AU2003287443A1 (en) Compositions and methods for pain reduction
AU2003212894A1 (en) Compositions and methods for treating diarrhea
AUPS236902A0 (en) Composition and method for treating hypertension
AU2003297573A1 (en) Compositions and methods for treating transplants
AU2003266815A1 (en) Immunoglobulin compositions and methods
EP1684771A4 (en) Composition and method
AU2003286674A1 (en) Nutritional supplement composition and method
AU2002950437A0 (en) Zinc Glycerodlate Composition and Method for Manufacture Thereof
AU2003222058A1 (en) Materials and methods for inhibiting wip-1
AU2003295574A1 (en) Method and compositions for temporarily incapaciting subjets
AU2003281708A1 (en) Method for manufactuing varistor and varistor
AU2003225710A1 (en) Composition and method for enhancing immune response
AU2003210474A1 (en) Composition and method for inhibiting hypersensitivity
AU2003275240A1 (en) Methods and compositions for soluble cpg15
AU2003212866A1 (en) Controlled release compositions and methods for using same
AU2003303948A1 (en) Compositions and methods for preventing infection
AU2003275069A1 (en) Compositions and methods for preventing infection
AU2003202264A1 (en) Composition and method for inhibiting hypersensitivity
AU2003214606A1 (en) Compositions and methods for treating mdma-induced toxicity
AU2003245524A1 (en) Cryosurgery compositions and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase